About Riluzole
Class: | Antineoplastic agent; Glutamate release inhibitor
Use: | Treatment of amyotrophic lateral sclerosis (ALS) to prolong survival and time to tracheostomy
Adult dose: | 50 mg orally twice daily
Pediatric dose: | Safety and efficacy not established in pediatric populations
Side effects: | Nausea, diarrhea, asthenia, dizziness, elevated liver enzymes, headache
Contraindications: | Hypersensitivity to riluzole or any component of the formulation; significant liver impairment
Storag
Drug Class
Antineoplastic agent; Glutamate release inhibitor
Uses & Indications
Treatment of amyotrophic lateral sclerosis (ALS) to prolong survival and time to tracheostomy
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Ascend laboratories Ltd, U.S.A
Package Size
60s
Price & Supplier
Price in UAE: AED 241.50
Dosage Information
Adult Dose
50 mg orally twice daily
Pediatric Dose
Safety and efficacy not established in pediatric populations
Side Effects
Nausea, diarrhea, asthenia, dizziness, elevated liver enzymes, headache
Contraindications & Precautions
Hypersensitivity to riluzole or any component of the formulation; significant liver impairment
Important Warnings
Monitor liver function tests prior to and during treatment; risk of hepatotoxicity; may cause dizziness; caution in patients with hepatic impairment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.